Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer

Tarsus Pharmaceuticals appointed Neera Clase as Chief Commercial Officer effective Nov. 1, 2026, converting her interim role that began in July 2026 into a permanent position. Clase previously served as SVP of Market Access at Tarsus and has 25+ years of biopharma experience at Acadia, Relypsa, and Abbott. She will lead commercial strategy for XDEMVY and planning across the pipeline, including two Phase 3 retina programs.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.